Drug Development For Cancer And Diabetes
Download Drug Development For Cancer And Diabetes full books in PDF, epub, and Kindle. Read online free Drug Development For Cancer And Diabetes ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author |
: K. Saravanan |
Publisher |
: CRC Press |
Total Pages |
: 393 |
Release |
: 2020-08-30 |
ISBN-10 |
: 9781000639988 |
ISBN-13 |
: 1000639983 |
Rating |
: 4/5 (88 Downloads) |
Synopsis Drug Development for Cancer and Diabetes by : K. Saravanan
Key features include: Details the role of plants for the treatment and management of cancer and diabetes Discusses the role of phytocompounds as ligands for cancer and diabetic targets Reviews plants and the potential of phytochemicals as antidiabetic and anticancer drugs Explores the green biosynthesis of nanoparticles and their treatment efficiency
Author |
: Anne Le |
Publisher |
: Springer |
Total Pages |
: 186 |
Release |
: 2018-06-26 |
ISBN-10 |
: 9783319777368 |
ISBN-13 |
: 331977736X |
Rating |
: 4/5 (68 Downloads) |
Synopsis The Heterogeneity of Cancer Metabolism by : Anne Le
Genetic alterations in cancer, in addition to being the fundamental drivers of tumorigenesis, can give rise to a variety of metabolic adaptations that allow cancer cells to survive and proliferate in diverse tumor microenvironments. This metabolic flexibility is different from normal cellular metabolic processes and leads to heterogeneity in cancer metabolism within the same cancer type or even within the same tumor. In this book, we delve into the complexity and diversity of cancer metabolism, and highlight how understanding the heterogeneity of cancer metabolism is fundamental to the development of effective metabolism-based therapeutic strategies. Deciphering how cancer cells utilize various nutrient resources will enable clinicians and researchers to pair specific chemotherapeutic agents with patients who are most likely to respond with positive outcomes, allowing for more cost-effective and personalized cancer therapeutic strategies.
Author |
: Derek LeRoith |
Publisher |
: Springer Science & Business Media |
Total Pages |
: 290 |
Release |
: 2011-09-18 |
ISBN-10 |
: 9781461405986 |
ISBN-13 |
: 146140598X |
Rating |
: 4/5 (86 Downloads) |
Synopsis Insulin-like Growth Factors and Cancer by : Derek LeRoith
The book will detail the history, successes, and failures of targeted therapies for cancer, with a particular focus on IGF systems and cancer.
Author |
: Jie Jack Li |
Publisher |
: John Wiley & Sons |
Total Pages |
: 595 |
Release |
: 2013-04-12 |
ISBN-10 |
: 9781118354476 |
ISBN-13 |
: 1118354478 |
Rating |
: 4/5 (76 Downloads) |
Synopsis Drug Discovery by : Jie Jack Li
Sets forth the history, state of the science, and future directions of drug discovery Edited by Jie Jack Li and Nobel laureate E. J. Corey, two leading pioneers in drug discovery and medicinal chemistry, this book synthesizes great moments in history, the current state of the science, and future directions of drug discovery into one expertly written and organized work. Exploring all major therapeutic areas, the book introduces readers to all facets and phases of drug discovery, including target selection, biological testing, drug metabolism, and computer-assisted drug design. Drug Discovery features chapters written by an international team of pharmaceutical and medicinal chemists. Contributions are based on a thorough review of the current literature as well as the authors' firsthand laboratory experience in drug discovery. The book begins with the history of drug discovery, describing groundbreaking moments in the field. Next, it covers such topics as: Target identification and validation Drug metabolism and pharmacokinetics Central nervous system drugs In vitro and in vivo assays Cardiovascular drugs Cancer drugs Each chapter features a case study, helping readers understand how science is put into practice throughout all phases of drug discovery. References at the end of each chapter serve as a gateway to groundbreaking original research studies and reviews in the field. Drug Discovery is ideal for newcomers to medicinal chemistry and drug discovery, providing a comprehensive overview of the field. Veterans in the field will also benefit from the perspectives of leading international experts in all aspects of drug discovery.
Author |
: Janos Fischer |
Publisher |
: John Wiley & Sons |
Total Pages |
: 320 |
Release |
: 2021-02-03 |
ISBN-10 |
: 9783527826858 |
ISBN-13 |
: 3527826858 |
Rating |
: 4/5 (58 Downloads) |
Synopsis Successful Drug Discovery, Volume 5 by : Janos Fischer
Filled with unique insights into current drugs that have made it to the marketplace In the fifth volume of Successful Drug Discovery, the inventors and primary developers of drugs that made it to the market tell the story of the drug's discovery and development. Case studies of drugs from different therapeutic fields reveal the all-too-often unpredictable path from the first drug candidate molecule to the successfully marketed drug. In addition, this new volume addresses overarching topics for drug discovery, such as drug discovery in academia, and discusses currently important classes of small molecule as well as biological drugs. Comprehensive in scope, the book's nine chapters provide a representative cross-section of the present-day drug development effort. The authoritative fifth volume is filled with relevant data and chemical information, as well as the insight and experience of the best contemporary drug creators. This important volume: - Puts the focus on recently introduced drugs that have not yet made it into standard textbooks or general references - Contains information and insight that is new and often not even available from the primary literature - Reveals what it takes to successfully develop a drug molecule that has made it all the way to the market - Is endorsed and supported by the International Union of Pure and Applied Chemistry (IUPAC) Written for medicinal chemists, pharmaceutical chemists, organic chemists, Successful Drug Discovery, Volume Five reveals the most recent techniques used by drug innovators in the drug development process.
Author |
: Michael R. Bleavins |
Publisher |
: John Wiley & Sons |
Total Pages |
: 559 |
Release |
: 2011-09-20 |
ISBN-10 |
: 9781118210420 |
ISBN-13 |
: 1118210425 |
Rating |
: 4/5 (20 Downloads) |
Synopsis Biomarkers in Drug Development by : Michael R. Bleavins
Discover how biomarkers can boost the success rate of drug development efforts As pharmaceutical companies struggle to improve the success rate and cost-effectiveness of the drug development process, biomarkers have emerged as a valuable tool. This book synthesizes and reviews the latest efforts to identify, develop, and integrate biomarkers as a key strategy in translational medicine and the drug development process. Filled with case studies, the book demonstrates how biomarkers can improve drug development timelines, lower costs, facilitate better compound selection, reduce late-stage attrition, and open the door to personalized medicine. Biomarkers in Drug Development is divided into eight parts: Part One offers an overview of biomarkers and their role in drug development. Part Two highlights important technologies to help researchers identify new biomarkers. Part Three examines the characterization and validation process for both drugs and diagnostics, and provides practical advice on appropriate statistical methods to ensure that biomarkers fulfill their intended purpose. Parts Four through Six examine the application of biomarkers in discovery, preclinical safety assessment, clinical trials, and translational medicine. Part Seven focuses on lessons learned and the practical aspects of implementing biomarkers in drug development programs. Part Eight explores future trends and issues, including data integration, personalized medicine, and ethical concerns. Each of the thirty-eight chapters was contributed by one or more leading experts, including scientists from biotechnology and pharmaceutical firms, academia, and the U.S. Food and Drug Administration. Their contributions offer pharmaceutical and clinical researchers the most up-to-date understanding of the strategies used for and applications of biomarkers in drug development.
Author |
: Beverly A. Teicher |
Publisher |
: Springer Science & Business Media |
Total Pages |
: 315 |
Release |
: 2013-11-11 |
ISBN-10 |
: 9781461581529 |
ISBN-13 |
: 1461581524 |
Rating |
: 4/5 (29 Downloads) |
Synopsis Anticancer Drug Development Guide by : Beverly A. Teicher
Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia comprehensively review and describe the arduous process of cancer drug discovery and approval. They focus on using preclinical in vivo and in vitro methods to identify molecules of interest, detailing the targets and criteria for success in each type of testing and defining the value of the information obtained from the various tests. They also define each stage of clinical testing, explain the criteria for success, and outline the requirements for FDA approval. A companion volume by the same editor (Cancer Therapeutics: Experimental and Clinical Agents) reviews existing anticancer drugs and potential anticancer therapies. These two volumes in the Cancer Drug Discovery and Development series reveal how and why molecules become anticancer drugs and thus offer a blueprint for the present and the future of the field.
Author |
: Bruce H. Littman |
Publisher |
: Cambridge University Press |
Total Pages |
: 385 |
Release |
: 2011-01-31 |
ISBN-10 |
: 9781139498722 |
ISBN-13 |
: 113949872X |
Rating |
: 4/5 (22 Downloads) |
Synopsis Translational Medicine and Drug Discovery by : Bruce H. Littman
This book focuses on the new discipline of translational medicine as it pertains to drug development within the pharmaceutical and biotechnology industry. It is essential for anyone interested in translational medicine from a variety of backgrounds: university institutes, medical schools, pharmaceutical companies and drug development researchers and decision-makers.
Author |
: Chukwuebuka Egbuna |
Publisher |
: Springer Nature |
Total Pages |
: 262 |
Release |
: 2021-08-20 |
ISBN-10 |
: 9783030729998 |
ISBN-13 |
: 3030729990 |
Rating |
: 4/5 (98 Downloads) |
Synopsis Dietary Phytochemicals by : Chukwuebuka Egbuna
This book presents comprehensive coverage on the importance of good nutrition in the treatment and management of obesity, cancer and diabetes. Naturally occurring bioactive compounds are ubiquitous in most dietary plants available to humans and provide opportunities for the management of diseases. The text provides information about the major causes of these diseases and their association with nutrition. The text also covers the role of dietary phytochemicals in drug development and their pathways. Later chapters emphasize novel bioactive compounds as anti-diabetic, anti-cancer and anti-obesity agents and describe their mechanisms to regulate cell metabolism. Written by global team of experts, Dietary Phytochemicals: A Source of Novel Bioactive Compounds for the Treatment of Obesity, Cancer and Diabetes describes the potentials of novel phytochemicals, their sources, and underlying mechanism of action. The chapters were drawn systematically and incorporated sequentially to facilitate proper understanding. This book is intended for nutritionists, physicians, medicinal chemists, drug developers in research and development, postgraduate students and scientists in area of nutrition and life sciences.
Author |
: Atta-ur-Rahman |
Publisher |
: Bentham Science Publishers |
Total Pages |
: 316 |
Release |
: 2014-05-20 |
ISBN-10 |
: 9781608058563 |
ISBN-13 |
: 1608058565 |
Rating |
: 4/5 (63 Downloads) |
Synopsis Frontiers in Clinical Drug Research: Diabetes and Obesity by : Atta-ur-Rahman
Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research. The first volume of this series features 6 chapters that cover a variety of topics including: -Angiotensin blockers -Agents targeting advanced glycation end products -Drugs and the peroxisome proliferator activated receptors -Topical Drugs for diabetic complications -Research on Liraglutide -Research on MicroRNAs as agents for diabetes treatment